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Abstract
Stereotactic body radiotherapy (SBRT) delivers a highly conformal and hypo-
fractionated radiation dose to a small target with minimal radiation applied to 
the surrounding areas. The spine is an ideal site for SBRT owing to its relative 
immobility, the potential clinical benefits of high-dose delivery to this area, and 
the presence of adjacent critical structures such as the spinal cord, esophagus, and 
bowel. However, with the potential for radiation myelopathy if the dose is delivered 
inaccurately or if the spinal cord dose limit is set too high, proper treatment plan-
ning techniques for SBRT are important. Intensity modulation techniques are useful 
for spinal SBRT because of a rapid dose falloff and spinal cord avoidance. In this 
chapter, various planning techniques will be discussed and reviewed.
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1. Introduction
Stereotactic body radiotherapy (SBRT) was developed using the concepts of 
stereotactic radiosurgery (SRS). SRS was conceived by neurosurgeons and physi-
cists in Sweden to allow the delivery of radiation to precise targets in the brain while 
minimizing injury to adjacent areas. The procedure delivers a high dose of radiation 
to the target accurately focused using multimodality imaging, such as computed 
tomography (CT), magnetic resonance imaging (MRI), and positron emission 
tomography/CT (PET/CT). The total dose is divided into several smaller doses of 
radiation, administered on separate days of treatment, typically in a single fraction 
or a few fractions. SRS treats tumors by destroying and distorting the DNA of these 
cells, in the same way as other forms of radiotherapy. As a result, these cells lose 
their ability to reproduce and die. Applied to the treatment of body tumors, the 
technique is called SBRT [1–4].
SBRT is also known as stereotactic ablative radiotherapy (SABR). SBRT ablates 
tumors by delivering precise and intensive radiation, guaranteeing minimal normal 
tissue complications. The characteristics of SBRT are summarized as follows: (1) a 
limited number of high dose-per-fraction treatments with a biologically equivalent 
dose (BED) of at least 75–100 as a minimum or even higher; (2) fields only slightly 
larger than gross tumor volume (GTV) with high accuracy even for moving targets, 
including the entire target with margins of 0.5–1.0 cm (i.e., exact delivery to tumor 
targets, sparing normal tissue); (3) dosimetry constructed to be very conformal, 
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with sharp gradients from high- to low-dose areas; and (4) secure patient fixation 
during treatment and accurate duplication of patient position between simulation 
and treatment [2, 5–8].
Because of the high dose in a single fraction or fewer than five fractions, organs 
at risk (OARs) can be greatly affected by slight positional errors. Therefore, 
positional errors should be minimized. The margins of expansion can be reduced 
through the immobilization and control of respiratory motion of patients. Various 
commercial treatment delivery units in conjunction with the immobilization and 
respiratory motion control systems are available for the delivery of SBRT.
SBRT is currently both in use and being investigated for use in treating malig-
nant or benign small- to medium-sized tumors in the body and at common disease 
sites, including the head and neck, lung, liver, abdomen, spine, and prostate. In par-
ticular, up to 70% of patients with malignancies are found to have skeletal involve-
ment on postmortem examination, with the spine being the most common location 
[9]. For the treatment of spinal tumors, an extremely rapid dose falloff between 
the vertebral body and the spinal cord should be achieved [10, 11]. Implementation 
of correct beam-shaping and image-guided techniques has improved SBRT safety 
margins as well as accuracy and efficiency while accurately meeting 3D tumor 
contours. Spinal SBRT demands the highest accuracy in dose placement. In addition 
to patient fixation and multi-image guidance, a sophisticated treatment planning 
system that accurately models highly modulated small field beams is an indispens-
able factor in achieving high accuracy of radiation delivery.
To achieve this high accuracy, appropriate treatment planning technique should 
be used. Therefore, we will discuss various planning techniques for spinal SBRT in 
this chapter.
2. Spinal stereotactic body radiotherapy
2.1 Spine
The spine is a frequent site of metastases from primary cancer of the prostate, 
lung, breast, and kidney. After the lung and liver, the skeletal system is the most 
frequent site of metastases [12, 13], and 30% of all patients with cancer develop 
bone metastases [12, 14, 15]. In particular, bone metastasis occurs in 85% of patients 
with breast, prostate, and bronchial carcinoma [12, 16]. Approximately 50% of 
all bone metastases occur in the spinal cord. Of these, 60–80% are located in the 
thoracic spine, followed by 15–30% in the lumbar spine and less than 10% in the 
cervical spine [12, 13].
If left untreated, spinal metastases can cause axial pain, vertebral body frac-
tures, radiculopathy, and the debilitating complications of metastatic epidural spi-
nal cord compression (MESCC) [9]. The major complications of spinal metastases 
include neurologic dysfunction [12, 17, 18] and potential hypercalcemia, reduced 
activity, and bone fractures, resulting in a reduced quality of life [12, 16].
In general, primary spinal tumors are treated surgically, with the goal of maxi-
mal tumor removal. Numerous important blood vessels and adjacent organs sur-
round the vertebrae. In particular, the spinal cord located in the vertebrae is a part 
of the central nervous system, which includes sensory and motor nerves. Complete 
resection of a tumor while preserving the nerve function of the spinal cord is 
difficult. In addition, vertebral instability due to tumor destruction or complete 
resection of the tumor must be considered, and fusion or fixation is often required 
for stability of the vertebrae. Depending on the malignancy of the tumor or the 
difficulty of complete resection, the patient may be treated with radiotherapy.
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2.2 Radiotherapy for spinal tumors
2.2.1 Conventional method
Traditional radiotherapy methods of treating spinal tumors use large field 
radiation to treat the entire pathological vertebra and to treat one or two vertebral 
bodies, generally above and below the disease. This practice prevents missing the 
tumor owing to the limitations of diagnostic imaging and localization. In addition, 
the irradiation field of this technique is large but safe in the volume of the normal 
tissues irradiated because of the low biological effectiveness.
Large field radiation for spinal metastases has been the standard approach with 
outcomes of ~30% complete pain response and ~70% any response. The main 
limitation of the dose prescribed by traditional radiation techniques was the spinal 
cord. Overdosing radiation to the spinal cord has the devastating consequence of 
radiation-induced myelopathy that can leave the patient paralyzed. In addition to 
radiation myelopathy, possible toxicities include vertebral compression fractures 
and pain flares. Owing to the limitations of technology to prevent overdosing, clini-
cal trials of high-dose effects on spinal metastasis have not been possible [19].
2.2.2 Stereotactic body radiotherapy
To overcome the limitations of conventional radiotherapy for the spine, 
hypofractionated treatment has been proposed, to deliver a high dose per fraction 
(typically 10–20 Gy/fraction), in contrast to the conventional fractionated treat-
ment (2 Gy/fraction). The cumulative BED is significantly higher than that received 
in conventional treatment. Accurate delivery is of utmost importance owing to the 
high fractional dose and a small number of fractions. The delivery of an ablative 
dose to the target and rapid falloff doses away from the target enables minimization 
of the treatment toxicity to a tolerable level [20, 21]. In addition, there are other 
characteristics that distinguish SBRT from conventional radiotherapy, such as 
the number of beams used for treatment, the frequent use of non-coplanar beam 
arrangements, small or no beam margins on the penumbra, and the use of inho-
mogeneous dose distributions and dose-painting techniques ‘including IMRT’. All 
of these technology improvements result in the highly conformal dose distribution 
that characterizes the SBRT technique [2].
Hypofractionated spinal SBRT has been shown to effectively and rapidly alleviate 
pain and improve neurological function in patients with or without epidural cord 
compression. SBRT allows minimal radiation exposure outside the target; the most 
significant problem associated with this procedure is related to spinal cord dose 
tolerance. Depending on the vertebral level of spinal metastasis, adjacent organs 
should be considered OARs. The tolerance of OARs to radiation from conventional 
fractionated radiotherapy is based on the entire organ or on a considerably large irra-
diated volume. SBRT delivers a highly conformal, hypofractionated radiation dose to 
a small target with minimal exposure of the surrounding areas to radiation [22].
A new radiotherapy technology that allows for intensity-modulated radio-
therapy (IMRT) has emerged with spinal SBRT. IMRT is a technique designed to 
deliver a high biologically effective dose only to tumors within the vertebra for the 
purpose of tumor regression through permanent local control. The technique allows 
radiation beams to avoid the spinal cord, and even though a high dose is delivered to 
tumors, the dose received by the spinal cord is below the toxic threshold dose [23]. 
More details will be discussed in Section 3.
Table 1 lists maximum dose limits to a point or volume within several 
critical organs recommended for SBRT in one fraction (refer to TG-101 for 
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multiple-fraction dose constraints [2]). The recommended dose constraints are 
shown in max critical volume and the maximum dose to the given volume for each 
organ. These limitations have been determined based on the widely accepted radio-
surgery norms currently in practice. Regardless of these limitations, the participat-
ing centers are encouraged to adhere to the prudent treatment planning principle to 
avoid unnecessary radiation exposure to critical normal structures [24].
Serial tissue Max critical volume Max dose in critical 
volume (Gy)
End point (≥ Grade 3)
Spinal cord <0.035 cc 14 Gy Myelitis
<0.35 cc 10 Gy
<1.2 cc (SBRT only) 7 Gy (SBRT only)
Cauda equina <0.035 cc 16 Gy Neuritis
<5 cc 14 Gy
Sacral plexus <0.035 cc 18 Gy Neuropathy
<5 cc 14.4 Gy
Esophagus* <0.035 cc 16 Gy Stenosis/fistula
<5 cc 11.9 Gy
Ipsilateral brachial 
plexus
<0.035 cc 17.5 Gy Neuropathy
<3 cc 14 Gy
Heart/pericardium <0.035 cc 22 Gy Pericarditis
<15 cc 16 Gy
Great vessels* <0.035 cc 37 Gy Aneurysm
<10 cc 31 Gy
Trachea* and larynx <0.035 cc 20.2 Gy Stenosis/fistula
<4 cc 10.5 Gy
Skin <0.035 cc 26 Gy Ulceration
<10 cc 23 Gy
Stomach <0.035 cc 16 Gy Ulceration/fistula
<10 cc 11.2 Gy
Duodenum* <0.035 cc 16 Gy Ulceration
<5 cc 11.2 Gy
Jejunum/ileum* <0.035 cc 15.4 Gy Enteritis/obstruction
<5 cc 11.9 Gy
Colon* <0.035 cc 18.4 Gy Colitis/fistula
<20 cc 14.3 Gy
Rectum* <0.035 cc 18.4 Gy Proctitis/fistula
<20 cc 14.3 Gy
Renal hilum/vascular 
trunk
<2/3 volume 10.6 Gy Malignant hypertension
Parallel tissue Critical volume (cc) Max dose in critical 
volume (Gy)
End point (≥Grade 3)
Lung (right and left) 1000 cc 7.4 Gy Pneumonitis
Renal cortex (right 
and left)
200 cc 8.4 Gy Basic renal function
*Avoid circumferential irradiation.
Table 1. 
One fraction dose constraints of several critical organs from RTOG 0613 [24].
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2.2.3 SBRT delivery systems
Various commercial treatment delivery units can be used to deliver SBRT 
[1, 5, 7], as shown in Figure 1. They all have the capability of image-guided radio-
therapy, enabling tumor or target localization prior to treatment delivery and allow-
ing treatment setup uncertainty to be significantly reduced. All delivery units, with 
the exception of proton therapy, used as photon-based SBRT, are linear accelerators 
(LINACs). There are several types of image-guidance equipment: 2D imaging types, 
including room-mounted or gantry-mounted orthogonal kilovoltage (kV) radio-
graphs and fluoroscopy, and 3D imaging types including kV or megavoltage (MV) 
cone-beam CT (CBCT) and CT-on-rails in room.
In addition to general LINACs, there are many types of treatment systems. The 
CyberKnife (CK, Accuray Inc., Sunnyvale, CA, USA) unit has a six-axis robotic 
manipulator that enables delivery of the beam to the target from many different 
directions in order to minimize radiation exposure to nearby organs. A pair of 
orthogonally positioned imaging systems enables monitoring of the target motion, 
with automatic correction. CK is a commonly used modality for SBRT owing to 
its highly conformal dose distributions, steep gradient, and near real-time image-
guidance system. The helical tomotherapy (HT, Accuray) unit is a special device 
performing continuous 360° rotations using a binary multi-leaf collimator (MLC), 
with the treatment couch moving continuously during the treatment [1].
Each treatment delivery system has strengths and weaknesses. An appropriate 
treatment delivery system and corresponding optimal planning technique should be 
used for successful and safe treatment.
3. SBRT planning techniques
SBRT is a high-precision radiotherapy technique that utilizes the high doses of 
radiation in a single fraction or a few fractions, as mentioned in the above sections. 
In principle, three-dimensional conformal radiotherapy (3D-CRT) planning can be 
applied to SBRT. When the beams at multiple angles are concentrated at the center 
of small lesions, a high-dose heterogeneity that contributes to a steep dose gradient 
Figure 1. 
Commercial treatment delivery units. From left to right are versa HD (Elekta AB), Radixact (Accuray Inc.), 
and CyberKnife M6 (Accuray Inc.).
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at the target edge appears and may be desirable in terms of normal tissue sparing 
and dose escalation to the GTV [1].
To treat a spinal tumor, conventionally fractionated 3D-CRT modifies the 
beam shape to match the projection of target volume at each gantry angle using an 
MLC. The accuracy of the shape of the beam projected onto the target depends on 
the width of leaves. MLC leaf widths of 2.5–10 mm have been reported for use in 
SBRT planning [25, 26].
However, delivery to the target is limited by tolerance of normal tissues, par-
ticularly the spinal cord, so it is necessary to irradiate the target with lower dose. In 
suboptimal cases, several side effects can occur, such as paraplegia, pain, increased 
steroid use, and reduced survival rate.
3.1 Intensity-modulated radiation treatment
The development of IMRT was a major improvement over 3D-CRT for 
SBRT [27]. IMRT allows for the radiation dose to conform more precisely to the 
shape of the tumor by modulating the intensity of the radiation beam and allows 
higher radiation doses to be focused to regions within the tumor, sparing the 
surrounding normal critical structures. In particular, when treating spinal tumors, 
intensity modulation allows production of a concave-shaped dose distribution with 
the exception of the spinal cord.
The IMRT technique uses computerized inverse planning. Conformal radio-
therapy is forward planning and depends on the skills of the treatment planner to 
determine the number, shape, and orientation of the beams. Inverse planning, in 
contrast, specifies the plan outcome in terms of the tumor dose and normal struc-
ture dose limits. The computer system then adjusts the beam intensities to identify a 
configuration best matched to the desired plan [28].
During the procedure, each beam is divided into several beam elements (beamlets) 
of a few millimeters, and the relative weight is optimized so that the desired dose distri-
bution appears. The optimization process involves inverse planning in which beamlet 
weights or intensities are adjusted to satisfy predefined dose criteria for the composite 
plan. When optimization is complete, an optimized fluence map generates a sequence 
of MLC leaves for each beam. The field at one gantry angle is subdivided into a set of 
subfields irradiated at a uniform beam intensity level. The subfields are shaped by the 
MLC, and the intensity-modulated field is obtained by summing several subfields.
The two most common methods of IMRT delivery are segmental (step-and-
shoot) and dynamic (sliding window). The difference between the two is the 
motion of MLC at a given gantry angle. In segmental MLC delivery, the beam is 
turned off while the leaves move until the next subfield is prepared. The advantage 
of the segmental MLC method is that it is easy to plan and no additional dose can 
occur while the MLC is moving to create the next subfield. On the other hand, the 
dose delivery is slow owing to the delay in turning the beam on and off, resulting 
in an increase in treatment time. In the dynamic MLC delivery, the MLC leaves are 
moving during irradiation. Each pair of leaves sweeps across target volumes under 
computer control. Dynamic MLC delivery offers better dose homogeneity for target 
volume and shorter treatment time in comparison to the segmental MLC; however, 
the larger total irradiated dose is a disadvantage.
Compared to 3D-CRT, the dose distribution can be made even more sophisti-
cated because target coverage and avoidance of critical structures located adjacent 
to the target volume are better. The more sophisticated implementation of SBRT has 
become possible with the IMRT technique. The technique mentioned in this section 
(Section 3.1) was the IMRT technique with a fixed gantry, and IMRT with a rotating 
gantry will be discussed in the following section (Section 3.2).
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3.2 Intensity-modulated arc therapy
Intensity-modulated arc therapy (IMAT) is a combined technique of IMRT 
and rotational treatment. When performed for a C-shaped target with a sensitive 
structure in the concavity of the “C,” like a spinal tumor, the rotational treatment 
has a dosimetric advantage. The result of simulation that supports this is that when 
all the planning parameters except the beam angle number are constant, the dose 
becomes more homogeneous in the tumor and decreased in the critical structures as 
the number of angles increased [29].
IMAT uses rotational cone beams of varying aperture shapes and varying dose 
weightings to achieve intensity modulation. However, the speed of rotation  cannot 
have frequent and drastic variations owing to the weight of the LINAC gantry; 
therefore, the variations in dose weighting are primarily achieved through varying 
the machine dose weight. MLC moves dynamically to shape each subfield while 
the gantry is rotating and the beam is on continuously [30]. Arcs are approximated 
as multiple-shaped fields in a regular angular interval. One subfield is delivered at 
each arc. The next new arc is started to deliver the next subfield and so on until all 
the planned arcs and their subfields have been delivered. That is, overlapping arcs 
create intensity modulation.
To create more effective treatment plans, various techniques have been purposed 
within IMAT. Volumetric-modulated arc therapy (VMAT) and modulated arc 
therapy (mARC) are examples of such techniques. VMAT is a single or multi-arc 
form of IMRT technique that changes the dose rate and gantry speed while the gan-
try is rotating. Currently there are several VMAT systems available under various 
names (RapidArc, Varian Medical Systems, Palo Alto, CA, USA; SmartArc, Philips 
Radiation Oncology Systems, Fitchburg, WI, USA; and Elekta VMAT, Elekta, 
Stockholm, Sweden) [31]. The mARC technique as an alternative to VMAT is a 
rotational IMRT irradiation with burst mode delivery. Both the dose rate and gantry 
speed are modulated to allow for delivery of the correct dose per IMRT segment, 
and an MLC velocity servo is required to continuously adjust the leaf velocity to 
facilitate accurate, and timely, leaf positioning [32].
The technique is similar to HT, which is an IMRT technique that rotates in a 
helical form and will be discussed in Section 3.3. As compared with HT, IMAT has 
certain advantages: (1) IMAT eliminates the need for transferring the patient during 
treatment and avoids abutment issues as seen with serial HT, (2) IMAT retains 
the ability to use non-coplanar beams and arcs, and (3) IMAT uses a conventional 
LINAC; thus, complex rotational IMRT treatments and simple palliative treatments 
can be delivered with the same treatment unit [30].
The main advantages of rotational therapy compared to fixed-gantry IMRT 
are improved conformity of the dose distribution in the high-dose regions, as well 
as possible reduction of the treatment time. The short treatment time can lead to 
improved patient comfort and reduce the risk of movement. Moreover, shorter 
treatment times can be biologically beneficial. Radiation survival is not only a 
function of the total dose delivered but also depends on the duration of radiation 
delivery [33, 34]. IMAT offers the efficient use of monitor units (MUs). The number 
of MUs per treatment is correlated with the amount of scatter dose and leakage 
radiation, which could be important in view of the induction of secondary malig-
nancies [35]. The decrease in MUs achieved with IMAT partly addresses this issue, 
which is one of the major concerns with IMRT [36].
However, the complex nature of IMAT planning has been one of the primary barriers 
to routine clinical implementation. From one angle to the next in each VMAT arc, leaf 
motion between adjacent angles is limited by leaf travel speed and gantry rotation speed. 
Therefore, the technique has disadvantages such as difficulty and complexity of planning.
Ionizing and Non-ionizing Radiation
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3.3 Helical tomotherapy
HT is a radiotherapy modality that combines helical CT scanning with an 
MV linear accelerator. A 6 MV LINAC rotates on a ring gantry at a source-axis 
distance (SAD) of 85 cm, and the beam passes through a primary collimator into 
a fan-beam shape. During treatment, the ring gantry continuously rotates, while 
the couch is continuously translated through the rotating beam plane. The dose is 
thus delivered in a helical fashion. The ring gantry also contains a detector system 
that is mounted opposite the accelerator and is used to collect data for megavolt-
age CT (MVCT) acquisition. A beam stopper is used to reduce room-shielding 
 requirements [37].
The MVCT in HT is used as a tool to enhance image-guided daily treatment 
setup and positioning of the patient. Because SBRT usually requires a longer 
treatment period owing to the use of high-dose hypofraction, the patient must be 
fixed in place to limit the patient’s movement during treatment. However, patients 
with vertebral metastases, in particular, often move involuntarily during treatment 
owing to back pain that cannot be controlled. Therefore, it is important to ensure 
the accuracy of high-dose delivery and to avoid side effects of OARs on intrafrac-
tional movement. A daily MVCT image scan is generated prior to treatment to 
ensure accurate delivery of each treatment according to the patient’s anatomy on a 
particular day. This MVCT is integrated with the kilovoltage CT (kVCT) imaging 
plan to provide a reference for patient setup and positioning [38].
The fan-beam has an extension of 40 cm in the lateral direction and smaller or 
equal to 5 cm (typically 1.0, 2.5, and 5.0 cm) in the longitudinal direction at the 
isocenter. With the use of a compressed air-driven multi-leaf (64 leaves) binary 
collimator (MLC), radiation beams are shaped, and their intensities are modulated. 
The leaves are mounted on two opposite blocks, and each individual leaf is driven 
from open to closed state. The intensity modulation is achieved by controlling the 
length of time each leaf is open. Each leaf has a width of 6.25 mm (40 cm divided by 
64 leaves) and rapid transitioning (about 20 ms); thus it can produce a sufficiently 
accurate shape even within a short rotation period. Therefore, HT offers a very 
useful treatment modality of spinal SBRT by implementing image-guided radiation 
therapy (IGRT) and IMRT techniques.
For the treatment planning of each rotation, a rotation is divided into 51 projec-
tions (360°/7° = 51). For each projection, each MLC leaf has a unique opening time 
as shown in Figure 2 [39]. Unlike the usual LINAC radiotherapy, there are addi-
tional parameters: slice width, pitch factor, and modulation factor. These param-
eters influence both treatment time and quality of the treatment plan.
Slice width (or field width) is the longitudinal extent (i.e., in the y-direction) of 
the treatment field. For planning purposes, a nominal 1.0, 2.5, or 5.0 cm is selected. 
Pitch is defined as distance traveled by the couch per gantry rotation, divided by the 
slice width. With a lower pitch value, there is greater overlap between spirals. This 
factor influences the treatment time. Modulation factor is defined as the maximum 
leaf opening time divided by the average opening time of all leaves. This value 
can range from 1.0 to 10 (typically using from 1.5 to 3.5). For a complex treatment 
requiring a lot of MLC motion, a high modulation factor is selected.
One of the most important differences between the HT system and other 
radiotherapy systems is that the HT system does not have a flattening filter. The 
main advantages of an absent flattening filter are an increased dose rate, reduced 
scatter, reduced leakage, and reduced out-of-field doses [40, 41]. The main reason 
for allowing the nonuniform profile is that HT is a dedicated IMRT system, without 
the need for a flat dose profile. If it is still desired, the MLC can be used to modulate 
the treatment field to produce a flat dose distribution [42].
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In treating spinal tumors, the major requirement is minimization of the dose to 
the spinal cord. The dose gradient should be increased to improve the conformity 
while allowing increased heterogeneity in the tumor volume coverage. In addition, 
the slice width and pitch parameters are considered to increase cord avoidance and 
target coverage.
3.4 CyberKnife
CK is one of the representative delivery units of SBRT. As mentioned briefly in 
the above section, CK has uniquely different features compared with the common 
medical LINACs. The compact LINAC mounted on a computer-controlled six-axis 
robotic manipulator delivers radiation beams anywhere in the body with submil-
limeter accuracy. The integrated orthogonally positioned kV X-ray imaging system 
is utilized to monitor the patient position throughout the course of radiotherapy. 
Patients are positioned automatically or manually by a therapist by matching 
fiducial markers or bony anatomy from X-ray images to digital reconstructed 
radiographs generated by CT simulation [43].
The robotic manipulator with six degrees of freedom can deliver the beam 
anywhere in space. Accordingly, the beam position and orientation can be adjusted 
by the robot to accommodate changes in target position and orientation during 
treatment without the need to move the patient.
The beam field size is controlled through various collimation types: 12 fixed cone 
collimators or an Iris variable collimator (Accuray) consisting of 12 tungsten leaves 
that produce beam diameters ranging from 5 to 60 mm (defined at 800 mm distance 
from the X-ray source) [44]. Furthermore, to compensate for the limit caused by the 
fixed field size, an MLC has recently been introduced for the CK [45]. The new MLC 
system consists of 41 leaf pairs, each with a width of 2.5 mm. The maximum field 
size is 12 × 10.25 cm. This new system allows the fields to be shaped matching the 
tumor shape and allows reduction of treatment time. In particular, using the MLC 
offers a dosimetric advantage for targets near OARs, as shown in Figure 3 [46].
The unit delivers multiple isocentric or non-isocentric photon beams to a desired 
target from many different angles through a robotic arm, as well as optic image 
guidance for motion management. The isocentric treatment planning is similar to 
Figure 2. 
Illustration of the helical tomotherapy delivery. Copyright © Journal of Medical Physics.
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that of the Gammaknife (Elekta) and conventional LINACs, which have a fixed 
mechanical center of the gantry and collimator. The location of the isocenter is not 
limited, providing a great advantage over many other delivery units. However, this 
advantage can be overcome by using inverse planning; the final target dose distribu-
tions can be manipulated to a certain level by modifying the order of the targets as 
well as the contours and dose limits assigned to the target and critical organs.
In non-isocentric treatment planning, radiation beams are delivered to a specific 
portion of the tumor without couch repositioning. This technique makes the high-
dose isodose lines match the target shape and avoid nearby critical organs. Therefore, 
non-isocentric planning is very useful for treatment of irregularly shaped targets. 
CK, which is available with both plans, is advantageous for combining the rapid dose 
falloff of isocentric plans with the dose conformity of non-isocentric plans [1].
3.5 Planning considerations
In spinal SBRT, the target volume includes the involved vertebral body and 
both left and right pedicles and the grossly visible tumor, if a paraspinal or epi-
dural lesion is present. The target volume is generally delineated with no margin. 
However, depending on the treatment system, a beam aperture margin of 2–3 mm 
beyond the target volume is allowed to ensure adequate dose coverage of the target. 
This margin can be reduced to 0–1 mm in the area of the spinal cord to meet spinal 
cord dose constraints. The target volume may be selected at the discretion of the 
treating radiation oncologist based on the extent of tumor involvement. In any cir-
cumstance in which there is an epidural or paraspinal soft tissue tumor component, 
the visible epidural or paraspinal tumors are included in the target volume [24].
Normal tissue contouring is required starting at 10 cm above the target volume 
to 10 cm below the target. The treatment plan should be established according to the 
recommended maximum dose limit for several critical organs, as shown in Table 1. 
Figure 3. 
Dose-volume parameters in circular collimator and multi-leaf collimator (MLC) plans for 1–7 cm brain target 
volumes. (White bars indicate multi-leaf collimator (MLC) and gray indicate circular collimator.) Copyright 
© 2017, Oxford University Press.
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Among the dose-limiting critical OARs, the spinal cord is a key concern. Because 
of the nature of radiosurgery with a rapid dose falloff, there is a radiation dose 
gradient within the diameter of the spinal cord. Therefore, a partial spinal cord 
volume defined as from 5 to 6 mm above to 5–6 mm below the target volume is used. 
The partial or absolute volume spinal cord constraints are applied to each treated 
spine level when the patient has multiple spine levels treated. Any spinal cord dose 
exceeding this constraint is not acceptable and is a major deviation [24].
Successful treatment planning requires 90% coverage of the target volume by 
the prescribed dose. Typically, the 80–90% isodose line is used as the prescription 
line, although the prescription isodose line may be different depending on the 
delivery system. Coverage of <90% of the target volume is an acceptable variation, 
and any coverage of <80% of the target volume is an unacceptable deviation. The 
treatment plan is acceptable as long as ≥90% of the target volume receives the 
prescribed dose. It should be noted, however, that owing to the irregular shape of 
the target volume and the location of the spinal cord, hot spots may be created in 
the immediate vicinity outside of the target volume [24].
Because of the characteristics of the spinal SBRT, in the case of a beam with a 
small size, the higher the beam energy, the larger the beam penumbra as a result 
of lateral electron transport in the medium. The commonly available 5 mm MLC 
leaf width has been found to be adequate for most applications, with negligible 
improvements using the 3 mm leaf width MLC for all but the smallest lesions 
(<3 cm in diameter). A 6 MV photon beam, available on most modern treatment 
machines, provides a reasonable compromise between the beam penetration and 
penumbra characteristics. Additionally, beam arrays should be placed mostly in the 
posterior direction to avoid entrance of the radiation beam through the lungs. In the 
case of arc rotation techniques, every effort should be used to limit the passage of 
radiation through the lungs [2].
4. Comparison of plan result
In Section 3, several spinal SBRT planning techniques were discussed. Because 
the planning technique should be selected depending on the patient’s condition 
or situation, numerous studies have been performed to compare various planning 
techniques for treating spinal tumors. To evaluate the results of each plan for spinal 
SBRT, the following quantitative parameters were used [22, 47–50].
• Conformity index (CI): a measure of the dose coverage to the planned target 
volume (PTV).
• Dice similarity coefficient (DSC): a spatial overlap index and a reproducibility 
validation metric [51].
• Homogeneity index (HI): a measure of uniformity of the dose within the target 
volume.
• PTV coverage: 100% of the PTV receiving the prescribed dose [52].
• Spinal cord dose: maximum dose to the spinal cord.
• High-dose spillage: The cumulative volume of all tissue outside the PTV receiv-
ing a dose >105% of prescription dose should be no more than 15% of the PTV 
volume [53].
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• Intermediate-dose spillage (R50% and D2cm): the falloff gradient located 
outside of the PTV.
R50%: volume that received 50% of the prescribed dose/PTV volume
D2cm: maximum dose in terms of the percentage of the prescribed dose at 2 cm 
beyond the PTV in any direction
• Equivalent uniform dose (EUD): the absorbed dose that, if homogeneously 
delivered to a tumor, causes the same expected number of clonogens to survive 
as does the actual nonhomogeneous absorbed dose distribution.
• Biological effective dose (BED): the dose producing equivalent biological effect 
regardless of dose uniformity or fractionations.
• Gamma index: the standard method for planar dose verification in IMRT 
QA; calculates the quantity γ for each point of interest using preselected dose 
difference (DD) and distance to agreement (DTA) criteria and then uses the γ 
value to determine the outcome (pass-fail) of the IMRT QA [53].
In addition, plans were evaluated by the treatment delivery time (beam irradi-
ated time) or the target point dose for the phantom measured in the ion chamber.
Zach et al. compared VMAT to static beam IMRT for spinal SBRT. The plans 
were compared for conformity, homogeneity, treatment delivery time, spinal 
cord dose, and Dmax of the spinal cord and V 10 Gy, which is the volume of the 
spinal cord exposed to at least 10 Gy. The authors also compared the monitor units 
required in each plan to compute the net irradiated time.
All evaluated parameters were shown to favor the VMAT plans over the IMRT 
plans. Dmin for PTV in the IMRT was significantly lower than that in the VMAT 
plan. The DSC and treatment time were found to be significantly better for the 
VMAT plans than for the IMRT plans. A reduction of almost 50% in the net treat-
ment time was calculated. The authors reported that VMAT provides better con-
formity, homogeneity, and spinal cord dose. They also suggested that the shorter 
treatment time is a major advantage and not only provides convenience for patients 
experiencing pain but also contributes to the precision of this high-dose radio-
therapy [47].
In another study, Choi et al. compared the treatment planning performance 
of RapidArc (i.e., VMAT) and CK for spinal SBRT. The optimized dose priorities 
for both plans were similar for all patients. The highest priority was to provide 
sufficient dose coverage to the PTV while limiting the maximum dose to the 
spinal cord. Plan quality was evaluated with respect to PTV coverage, CI, high-
dose spillage, intermediate-dose spillage, and maximum dose to the spinal cord, 
which are criteria recommended by the RTOG 0631 spine and 0915 lung SBRT 
protocols.
The mean CI ± standard deviation (SD) values of the PTV were 1.11 ± 0.03 and 
1.17 ± 0.10 for RapidArc and CK, respectively. On average, the maximum dose 
delivered to the spinal cord in CK plans was approximately 11.6% higher than that 
in RapidArc plans. High-dose spillages were 0.86 and 2.26% for RapidArc and 
CK, respectively. Intermediate-dose spillage characterized by D2cm was lower for 
RapidArc than for CK; however, R50% was not statistically different between the 
plans. Although both systems can create highly conformal volumetric dose distri-
butions, the study of Choi et al. shows that RapidArc was associated with lower 
high- and intermediate-dose spillages than was CK. The authors also suggested that 
RapidArc plans for spinal SBRT may be superior to CK plans [48].
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Sahgal et al. compared the treatment planning quality of the CK and Novalis 
(BrainLAB AG, Heimstetten, Germany) systems for vertebral body SBRT. Physical 
parameters and biological modeling parameters such as PTV dose coverage, dose 
conformity, EUD, integral BED, and a generalized BED were used to compare the 
treatment plans.
In the study, both the CK and Novalis treatment plans fulfilled the specified 
requirements with comparable PTV dose coverage and dose conformity. For the 
target volume, CK plans produced significantly higher values of all calculated 
parameters to the PTV. For OARs, CK plans produced a somewhat lower dose to 
small volumes (0.1–1 cm3) of the spinal cord and esophagus but exposed larger 
volumes of these structures to a low dose as compared to the Novalis plans.
The authors reported that restricting the dose to a small volume of the spinal 
cord and esophagus resulted in a modest decrease in the dose to 1 cm3 volume of 
these structures for CK planning but at the expense of a larger volume of these 
structures exposed to low-dose levels [49].
In another study, Kim et al. compared the planning characteristics for hypo-
fractionated spinal SBRT administered using three treatment techniques (IMRT, 
mARC, and HT). The factors evaluated for spinal SBRT planning were dose cover-
age, cord avoidance, target conformity, homogeneity, and dose spillage.
Target dose coverage was 82.74 ± 3.35, 80.92 ± 0.81, and 85.01 ± 7.27% for IMRT, 
mARC, and HT, respectively. The authors reported that HT was therefore a power-
ful technique with respect to target coverage. The spinal cord dose for HT (mean, 
1763.96 cGy; SD, 164.48) was significantly different from those for mARC (mean, 
1991.75 cGy; SD, 248.00) and IMRT (mean, 2053.24 cGy; SD, 164.48). In addi-
tion, the partial spinal cord volume at 2000 cGy for HT (mean, 0.12 cc; SD, 0.01) 
was significantly different from those for IMRT and mARC (0.50 ± 0.10 cc and 
0.56 ± 0.25 cc, respectively). The CIs were 1.30 ± 0.12, 1.08 ± 0.05, and 1.36 ± 0.23 
for IMRT, mARC, and HT planning, respectively. mARC showed the highest con-
formity. Regarding HI, HT (mean, 1763.96 cGy; SD, 164.48) differed statistically 
from both mARC (mean, 1991.75 cGy; SD, 248.00) and IMRT (mean, 2053.24 cGy; 
SD, 164.48) with respect to the spinal cord dose.
HT used a narrow field fan-beam and exhibited remarkable improvement of 
target coverage and cord dose, offering an important benefit to spinal SBRT. mARC 
had the highest target conformity and showed more favorable high- and interme-
diate-dose spillage than did HT and IMRT. These three planning techniques have 
different advantages. The authors suggested utilizing different planning techniques 
according to the cases. In the case of spinal SBRT, HT should be used for cord 
avoidance. In some cases, such as for a short treatment duration when the patient is 
considered to be in poor general condition, mARC can be used [22].
Gallo et al. performed end-to-end (E2E) testing for a set of representative spinal 
targets planned and delivered using four different treatment planning systems and 
delivery systems, specifically HT, Vero, TrueBeam with flattening filter free (FFF) 
and flattened, and CK, to evaluate the various capabilities of each. An anthropo-
morphic E2E SBRT phantom was simulated and treated on each system to evaluate 
agreement between measured and planned doses. The phantom accepted 0.007 cm3 
ion chambers in the thoracic region and radiochromic film in the lumbar region.
Ion chamber measurements in the thoracic targets resulted in an overall average 
difference of 1.5% with planned doses. Specifically, measurements agreed with 
the treatment planning system to within 2.2, 3.2, 1.4, 3.1, and 3.0% for all three 
measureable cases on HT, Vero, TrueBeam (FFF), TrueBeam (flattened), and 
CK, respectively. Film measurements for the lumbar targets resulted in average 
global gamma index passing rates of 100 at 3%/3 mm, 96.9 at 2%/2 mm, and 61.8 
at 1%/1 mm, with a 10% minimum threshold for all plans on all platforms. Local 
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gamma analysis was also performed with similar results. While gamma passing 
rates were consistently accurate across all platforms through 2%/2 mm, treatment 
beam-on delivery times varied greatly among the platforms, with TrueBeam (FFF) 
the shortest, averaging 4.4 min, TrueBeam using flattened beam at 9.5 min, HT at 
30.5 min, Vero at 19 min, and CK at 46.0 min.
In the study, despite the complexity of the representative targets and their 
proximity to the spinal cord, all treatment platforms were able to create plans that 
meet all RTOG 0631 dose constraints and produced exceptional agreement between 
calculated and measured doses. However, there were differences in the plan charac-
teristics and significant differences in the beam-on delivery time between plat-
forms. Thus, the authors stated that clinical judgment is required in each particular 
case to determine the most appropriate treatment planning/delivery platform [50].
5. Conclusion
This chapter has described various planning techniques for spinal SBRT and 
summarized the studies comparing these techniques. The spine is a frequent site of 
tumor metastasis, but there are many important vessels and adjacent organs in the 
vicinity of the vertebrae. In particular, the spinal cord within the spine is part of the 
central nervous system. Radiotherapy is performed depending on the malignancy 
of the tumor or the difficulty of complete resection, considering potential spinal 
instability caused by the tumor destruction or complete resection. However, the 
major limitation of traditional radiotherapy is the tolerance dose of the spinal cord. 
If the spinal cord is irradiated with an overdose, toxicities such as radiation-induced 
myelopathy, vertebral compression fracture, or pain flare may occur. To over-
come the limitation of conventional radiotherapy, SBRT has been proposed. The 
technique of SBRT delivers a higher BED, within the range of what is considered 
locally curative. A conformal high-dose beam in a few fractions should be used, 
and an intensity modulation technique is required for the sparing of normal organs 
surrounding the spinal lesion. Various planning technologies based on intensity 
modulation technology are available, including IMRT with fixed gantry, IMAT, HT, 
and CK. Different planning techniques have their distinct features and advantages. 
Therefore, it is important to use appropriate treatment planning depending on the 
patient’s condition and situation.
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